First published online October 22, 2008
Journal of Cell Science 121, 2103e (2008)
© The Company of Biologists Limited
REV-ERB
– time for a change
Several sleep disorders are caused by the disruption of the circadian clock, which is underpinned by the fluctuating activity of transcription factors that periodically inhibit their own expression. The nuclear receptor REV-ERB
, which is activated by heme binding, stabilises the clock by repressing Bmal1 transcription – but could REV-ERB
be a good pharmacological target for circadian-rhythm disorders? On page 3629, Andrew Loudon and colleagues propose that it could. The authors use a FRET-based in vitro screen to identify a compound that promotes the formation of a complex between REV-ERB
and the nuclear receptor co-repressor (NCoR). In fibroblasts expressing Bmal1 or Rev-erba, they show, the expression level of both genes oscillates. Importantly, the addition of the REV-ERB
ligand causes phase shifts in BMAL1 and PER2 activity that change their directionality according to the phase of the circadian clock. Moreover, phase-dependent phase resetting also occurs in lung slices treated with the REV-ERB
ligand. The authors propose that the binding of REV-ERB
to endogenous ligands, such as heme, might be a mechanism of clock resetting; moreover, pharmacological modulation of REV-ERB
might offer a novel approach to the treatment of circadian-rhythm disorders.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
Related articles in JCS:
- Ligand modulation of REV-ERB
function resets the peripheral circadian clock in a phasic manner
- Qing Jun Meng, Andrew McMaster, Stephen Beesley, Wei Qun Lu, Julie Gibbs, Derek Parks, Jon Collins, Stuart Farrow, Rachelle Donn, David Ray, and Andrew Loudon
JCS 2008 121: 3629-3635.
[Abstract]
[Full Text]